Drug Testing Market Size, Share, Trends, Value 2032

Drug Testing Market

Drug Testing Market - By Product (Consumables and Rapid Testing Devices), By Sample Type (Urine Sample, Oral Fluid Samples, and Hair Samples), By End-Use (Drug Testing Laboratories, Workplace, and Hospitals), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 – 2032-

Category: Healthcare Report Format : PDF Pages: 166 Report Code: ZMR-6715 Published Date: Nov-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 3.07 Billion USD 5.94 Billion 7.6% 2023

Drug Testing Market Insights

According to a report from Zion Market Research, the global Drug Testing Market was valued at USD 3.07 Billion in 2023 and is projected to hit USD 5.94 Billion by 2032, with a compound annual growth rate (CAGR) of 7.6% during the forecast period 2024-2032.

This report explores market strengths, weakness, opportunities, and threats. It also provides valuable insights into the market's growth drivers, challenges, and the future prospects that may emerge in the Drug Testing Market industry over the next decade.

Global Drug Testing Market SizeRequest Free Sample

Global Drug Testing Market Overview

The report offers assessment and analysis of the Drug Testing market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Billion).

Drug Testing Market: Outlook

Drug testing is a procedure of making use of biological sample for determining presence as well as absence of metabolites or medicine. This procedure can be completed in various settings through use of myriad kinds of techniques. With the human body metabolizing different medicines at different rates, the timespan for determining the effect of a particular medicine on the human body can be specific and can vary extensively from one drug to another.

In spite of these hitches, drug testing plays a pivotal role in clinical settings as medical examination, collateral reporting, and patient self-reporting can understate the incidence of medicine utilized. Moreover, as per NIH researchers, drug testing should be performed along with physical or psychological assessment.

Furthermore, drug testing is utilized for validating current use of any drug. It also plays a key role in diagnosis, treatment, and identification of drug addiction in individuals. Moreover, urine drug testing method is one of the most accurate methods for drug identification in human body system as it is based on immunoassay technique.

Global Drug Testing MarketRequest Free Sample

Drug Testing Market: Growth Dynamics

Strict enforcement of laws by government authorities mandating drug testing as well as alcohol testing for security purpose as well as combating drug abuse in respective countries will drive market trends. Massive demand for workplace drug testing such as pre-employment drug testing, incident-driven as well as for-cause drug testing for staff, and post-employment drug testing or random drug testing for targeted staff has proliferated market scope in recent years. Moreover, drug testing is a harm reduction technique and has been used in many of European countries and in the U.S. Rise in roadside drug testing for ensuring road safety as well as reducing incidents of road collisions will culminate into massive growth of drug testing market in years to come. Need for monitoring as well as combating drug abuse has raised requirement for drug testing activities, thereby driving market trends.

Drug Testing Market: Report Scope

Report Attributes Report Details
Report Name Drug Testing Market
Market Size in 2023 USD 3.07 Billion
Market Forecast in 2032 USD 5.94 Billion
Growth Rate CAGR of 7.6%
Number of Pages 166
Key Companies Covered Quest Diagnostics Incorporated, Quidel Corporation, Bio-Rad Laboratories, Inc., Siemens Healthineers, Cordant Health Solutions, Legacy Medical Services, LLC, Laboratory Corporation of America Holdings, Agilent Technologies, Inc., Clinical Reference Laboratory (CRL), Inc., F. Hoffmann-La Roche, Drägerwerk AG & CO. KgaA, Abbott Laboratories, Thermo Fisher Scientific, Inc., and Omega Laboratories, Inc
Segments Covered By Product, By End-User, By Sample Type and By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2023
Historical Year 2018 to 2022
Forecast Year 2024 - 2032
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Furthermore, COVID-19 has resulted in closure of many manufacturing units due to lockdown and this has resulted into large number of layoffs in factories. In addition to this, many other industries including tourism, hotel, and travel industries have been severely affected due to COVID pandemic. This, in turn, has resulted in rise in stress, depression, and deteriorating mental condition/health among the working population, giving rise to intake of drugs. This has made drug testing a necessary tool for government for arresting drug consumption among persons affected due to job loss or under stress of losing their jobs during COVID-19 pandemic, thereby opening new vistas of growth for drug testing business. 

Competitive Landscape

Key players leveraging business space and profiled in Zion market research report include Quest Diagnostics Incorporated, Quidel Corporation, Bio-Rad Laboratories, Inc., Siemens Healthineers, Cordant Health Solutions, Legacy Medical Services, LLC, Laboratory Corporation of America Holdings, Agilent Technologies, Inc., Clinical Reference Laboratory (CRL), Inc., F. Hoffmann-La Roche, Drägerwerk AG & CO. KgaA, Abbott Laboratories, Thermo Fisher Scientific, Inc., and Omega Laboratories, Inc.

Regional Landscape

North America To Retain Market Dominance Over 2024-2032

Growth of drug testing market in North America over forecast timespan can be ascribed to large-scale presence of giant participants in countries such as the U.S. Apart from this, favorable compensation policies along with high acceptance of new drug testing tools will drive regional market trends.

Global Drug Testing Market SizeRequest Free Sample

With regional governments enforcing strict laws pertaining to drug abuse, the market for drug testing in North America is set to witness exponential growth over years to come. Legalization of cannabis in countries such as Canada and U.S. through passing of acts in parliament is likely to enlarge scope of drug testing market in North America over coming decade.

Drug Testing Market: Competitive Space

The global Drug Testing market profiles key players such as:

  • Quest Diagnostics Incorporated
  • Quidel Corporation
  • Bio-Rad Laboratories, Inc
  • Siemens Healthineers
  • Cordant Health Solutions
  • Legacy Medical Services, LLC
  • Laboratory Corporation of America Holdings
  • Agilent Technologies, Inc
  • Clinical Reference Laboratory (CRL), Inc
  • F. Hoffmann-La Roche
  • Drägerwerk AG & CO. KgaA
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc
  • Omega Laboratories, Inc

The global Drug Testing Market is segmented as follows:

By Product

By End-User

  • Drug Testing Laboratories
  • Hospitals
  • Workplace

By Sample Type

  • Urine Sample
  • Oral Fluid Samples
  • Hair Samples

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

Strict enforcement of laws by government authorities mandating drug testing as well as alcohol testing for security purpose as well as combating drug abuse in respective countries will drive market trends. Massive demand for workplace drug testing such as pre-employment drug testing, incident- driven as well as for-cause drug testing for staff, and post-employment drug testing or random drug testing for targeted staff has proliferated market scope in recent years. Moreover, drug testing is harm reduction technique and has been used in many of European countries and in the U.S. Rise in roadside drug testing for ensuring road safety as well as reducing incidents of road collisions will culminate into massive growth of drug testing market in years to come. Need for monitoring as well as combating drug abuse has raised requirement for drug testing activities, thereby driving market trends.

Furthermore, COVID-19 has resulted in closure of many manufacturing units due to lockdown and this has resulted into large number of layoffs in factories.

Global Drug Testing Market size worth at USD 3.07 Billion in 2023 and projected to USD 5.94 Billion by 2032, with a CAGR of around 7.6% between 2024-2032.

North America will contribute lucratively towards the global market value over the estimated timeline. The regional market surge is subject to large-scale presence of giant participants in countries such as the U.S. Apart from this, favorable compensation policies along with high acceptance of new drug testing tools will drive regional market trends. With regional governments enforcing strict laws pertaining to drug abuse, the market for drug testing in North America is set to witness exponential growth over years to come. Legalization of cannabis in countries such as Canada and U.S. through passing of acts in parliament is likely to enlarge scope of drug testing market in North America over coming decade.

   

The key market participants include Quest Diagnostics Incorporated, Quidel Corporation, Bio-Rad Laboratories, Inc., Siemens Healthineers, Cordant Health Solutions, Legacy Medical Services, LLC, Laboratory Corporation of America Holdings, Agilent Technologies, Inc., Clinical Reference Laboratory (CRL), Inc., F. Hoffmann-La Roche, Drägerwerk AG & CO. KgaA, Abbott Laboratories, Thermo Fisher Scientific, Inc., and Omega Laboratories, Inc.

 

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed